EDGAR Filing Documents for 0001193125-13-022374

Form 8-K - Current report:

SEC Accession No. 0001193125-13-022374

Filing Date

2013-01-24

Accepted

2013-01-24 17:13:01

Documents

Period of Report

2013-01-24

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d472910d8k.htm	8-K	35438
2	REGISTRATION RIGHTS AGREEMENT	d472910dex41.htm	EX-4.1	79566
3	COMMON STOCK PURCHASE AGREEMENT	d472910dex101.htm	EX-10.1	174552
4	PRESS RELEASE	d472910dex991.htm	EX-99.1	10807
5	PRESS RELEASE	d472910dex992.htm	EX-99.2	7425
6	BUSINESS OVERVIEW	d472910dex993.htm	EX-99.3	19386
7	RISK FACTORS	d472910dex994.htm	EX-99.4	140688
	Complete submission text file	0001193125-13-022374.txt		469108

Mailing Address 610N LINCOLN STREET WALTHAM MA 02451

Business Address 610N LINCOLN STREET WALTHAM MA 02451 781-890-1199

BG Medicine, Inc. (Filer) CIK: 0001407038 (see all company filings)